A Prospective Correlation of Tissue Histopathology With Nucleic Acid Yield in Metastatic Castration-Resistant Prostate Cancer Biopsy Specimens-Reference-Cited by-同舟云学术

A Prospective Correlation of Tissue Histopathology With Nucleic Acid Yield in Metastatic Castration-Resistant Prostate Cancer Biopsy Specimens

Published:2019-03 Issue:1 Volume:3 Page:14-22
ISSN:2542-4548
Container-title:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
language:en
Short-container-title:Mayo Clinic Proceedings: Innovations, Quality & Outcomes

Author:

Jimenez Rafael E.,Atwell Thomas D.,Sicotte Hughes,Eckloff Bruce,Wang Liguo,Barman Poulami,Sinnwell Jason P.,Eiken Patrick W.,McMenomy Brendan P.,Tan Winston,Wang Liewei,Carlson Rachel E.,Kohli Manish^ORCID

Funder

Mayo Clinic

Joseph and Gail Gassner

National Institutes of Health

National Cancer Institute

US Department of Defense

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

2. A prospective genome-wide study of prostate cancer metastases reveals association of Wnt pathway activation and increased cell cycle proliferation with primary resistance to abiraterone acetate-prednisone;Wang;Ann Oncol,2018

3. Integrative clinical genomics of advanced prostate cancer;Robinson;Cell,2015

4. The mutational landscape of lethal castration-resistant prostate cancer;Grasso;Nature,2012

5. Bone biopsy protocol for advanced prostate cancer in the era of precision medicine;Sailer;Cancer,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis of randomized controlled trials;Frontiers in Oncology;2023-10-06

2. Olaparib Efficacy in Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1, BRCA2, or ATM Alterations Identified by Testing Circulating Tumor DNA;Clinical Cancer Research;2022-11-01

3. Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment;Molecular Cancer Research;2022-09-22

4. Overcoming Obstacles in Liquid Biopsy Developments for Prostate Cancer;OncoTargets and Therapy;2022-08

5. Circulating Cell-Free DNA-Based Detection of Tumor Suppressor Gene Copy Number Loss and Its Clinical Implication in Metastatic Prostate Cancer;Frontiers in Oncology;2021-08-24